Maya Berg

Wilrijk, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in Oncology.

Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in Oncology.

Journal: Journal of medicinal chemistry

Published: January 26, 2026

Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

Journal: Journal of medicinal chemistry

Published: October 14, 2025

In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time.

In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time.

Journal: European journal of medicinal chemistry

Published: September 24, 2025

Biarylacetamides: a novel class of late-stage autophagy inhibitors.

Biarylacetamides: a novel class of late-stage autophagy inhibitors.

Journal: Autophagy reports

Published: September 18, 2025

Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Journal: Nature communications

Published: September 18, 2025

Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases.

Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases.

Journal: Journal of medicinal chemistry

Published: February 06, 2025

Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase-1- and Gasdermin-Dependent Cell Death.

Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase-1- and Gasdermin-Dependent Cell Death.

Journal: European journal of immunology

Published: September 19, 2024

Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically Active.

Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically Active.

Journal: Journal of extracellular vesicles

Published: November 02, 2023

Chemically diverse activity-based probes with unexpected inhibitory mechanisms targeting trypsin-like serine proteases.

Chemically diverse activity-based probes with unexpected inhibitory mechanisms targeting trypsin-like serine proteases.

Journal: Frontiers in chemistry

Published: November 04, 2022

Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis.

Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis.

Journal: International journal of molecular sciences

Published: September 07, 2021

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma.

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma.

Journal: Frontiers in oncology

Published: July 30, 2021

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Journal: Nature communications

Published: April 15, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026